Daniel Millar Email & Phone Number
Who is Daniel Millar? Overview
A concise factual answer block for searchers comparing this professional profile.
Daniel Millar is listed as Senior Director, CMC Development and Supply, Advanced Therapies and Vaccines, Bern at Johnson & Johnson Innovative Medicine, a with 100890 employees, based in New York, United States. AeroLeads shows a matched LinkedIn profile for Daniel Millar.
Daniel Millar previously worked as Senior Director, CMC Development and Supply, Advanced Therapies & Vaccines, Bern at Johnson & Johnson Innovative Medicine and Senior Director, Strategic Business Transformation, Quantitative Sciences, Janssen R&D at Janssen, Pharmaceutical Companies Of Johnson And Johnson. Daniel Millar holds Mba, Finance And Entrepreneurship from The University Of Chicago Booth School Of Business.
Email format at Johnson & Johnson Innovative Medicine
This section adds company-level context without repeating Daniel Millar's masked contact details.
Review company-level records connected to Daniel Millar before choosing the right outreach path.
About Daniel Millar
Experienced leader of business transformation with a demonstrated history across pharmaceutical R&D, commercial operation and supply chain. Skilled in Business Transformation, Mergers & Acquisitions Planning and Integration, Continuous Improvement, and Leadership Development. Strategic leader with a MBA focused in Finance and Entrepreneurship from The University of Chicago - Booth School of Business.
Daniel Millar's current company
Company context helps verify the profile and gives searchers a useful next step.
Daniel Millar work experience
A career timeline built from the work history available for this profile.
Senior Director, Cmc Development And Supply, Advanced Therapies & Vaccines, Bern
Current
Senior Director, Strategic Business Transformation, Quantitative Sciences, Janssen R&D
1. Lead and manage transformational cross-functional initiatives that are integral to the operational effectiveness objectives of Quantitative Sciences. 2. Assist the Global Head, Quantitative Sciences to formulate strategies and manage execution to ensure successful implementation, using scientific and business principles and best-in-class processes across the R&D enterprise. 3. Responsible for driving process, content and business impact for large, complex transformational projects, and coordinate the Quantitative Sciences portfolio of activities, projects and programs.
Director, Strategic Business Improvement
1. Developed business case and strategy for functional outsourcing in partnership with functional leaders for medical writing, data management and biostatistics and statistical programming. The new relationship with the selected business process outsourcing (BPO) organization in India delivers high quality deliverables at a favorable cost.2. Partnered with highest-value Compound Development Teams to identify and mitigate operational risk. Approach contributed to several on-time regulatory approvals of high-value assets.3. Supported Head of Global Clinical Operations to evolve operating model of clinical operations organization while increasing short-term performance.
Director, Strategic Business Improvement
Lead the development and implementation of a governance and operating model which defined a new way of working across R&D, Supply Chain and Commercial functions based on the unique opportunities and challenges of the organization.
Director, Strategic Business Improvement
Provide management consulting, project management and implementation support (leadership engagement, change management and strategy alignment) for strategic projects spanning Alzheimer's Immunotherapy Portfolio, a co-development and co-commercialization alliance for Alzheimer's therapies involving Janssen Pharmaceutical, a Johnson & Johnson company; Pfizer; and Elan. Strategic projects include elements of business development, alliance management, research and development, manufacturing and global commercialization.
Director, Strategic Business Improvement
Supported the Janssen EMEA Board on a long-term transformation program to adapt the EMEA commercial organization and operating model to align better to the needs of a emerging stakeholders and stakeholders with increasing influence. One key components was enhancing processes and capabilities to demonstrate and communicate the value of our products based on evidence in order to achieve and sustain market access. Another key component was increasing the connection and interaction of roles across the organization with customers.
Director, Process Excellence
Senior Consultant
Consultant, Continuous Improvement
1. Technical Operations Continuous Improvement Group -- identified opportunities, developed business cases and coached teams to implement and sustain improvement in pharmaceutical manufacturing plants in Europe, Latin American and the United States in areas including materials management/supply chain, GMP QA & QC and manufacturing while focusing on building leadership skills of local staff.2. As part of the Integration Office managed the planning and execution for the integration of DuPont Pharmaceuticals into BMS (a $7.8B acquisition including the R&D pipeline, manufacturing capabilities and commercial assets)
Colleagues at Johnson & Johnson Innovative Medicine
Other employees you can reach at jnj.com. View company contacts for 100890 employees →
Kévin Marion
Colleague at Johnson & Johnson Innovative MedicineNeuchâtel, Switzerland
View →
UK
Urszula Krówka
Colleague at Johnson & Johnson Innovative MedicineWarsaw, Mazowieckie, Poland
View →
AF
Alvaro Francisco Sousa Pinheiro
Colleague at Johnson & Johnson Innovative MedicineCampinas, São Paulo, Brazil
View →
WA
Waseem Akram
Colleague at Johnson & Johnson Innovative MedicineBengaluru, Karnataka, India
View →
RI
Ron Iversen
Colleague at Johnson & Johnson Innovative MedicineNew Hope, Pennsylvania, United States
View →
SN
Sean Nixon
Colleague at Johnson & Johnson Innovative MedicineMorristown, New Jersey, United States
View →
LC
Leilani Clarite
Colleague at Johnson & Johnson Innovative MedicinePhilippines
View →
TM
Tom Mackey
Colleague at Johnson & Johnson Innovative MedicineUnited States
View →
BH
Brian Henderson
Colleague at Johnson & Johnson Innovative MedicineOmaha Metropolitan Area, United States
View →
EM
Eileen Ma
Colleague at Johnson & Johnson Innovative MedicineSingapore
View →
Daniel Millar education
Mba, Finance And Entrepreneurship
Ba, Mathematics
R&D Leadership Program
R&D Leadership Program
Frequently asked questions about Daniel Millar
Quick answers generated from the profile data available on this page.
What company does Daniel Millar work for?
Daniel Millar works for Johnson & Johnson Innovative Medicine.
What is Daniel Millar's role at Johnson & Johnson Innovative Medicine?
Daniel Millar is listed as Senior Director, CMC Development and Supply, Advanced Therapies and Vaccines, Bern at Johnson & Johnson Innovative Medicine.
Where is Daniel Millar based?
Daniel Millar is based in New York, United States while working with Johnson & Johnson Innovative Medicine.
What companies has Daniel Millar worked for?
Daniel Millar has worked for Johnson & Johnson Innovative Medicine, Janssen, Pharmaceutical Companies Of Johnson And Johnson, Johnson & Johnson, Crucell, and Janssen Alzheimer Immunotherapy.
Who are Daniel Millar's colleagues at Johnson & Johnson Innovative Medicine?
Daniel Millar's colleagues at Johnson & Johnson Innovative Medicine include Kévin Marion, Urszula Krówka, Alvaro Francisco Sousa Pinheiro, Waseem Akram, and Ron Iversen.
How can I contact Daniel Millar?
You can use AeroLeads to view verified contact signals for Daniel Millar at Johnson & Johnson Innovative Medicine, including work email, phone, and LinkedIn data when available.
What schools did Daniel Millar attend?
Daniel Millar holds Mba, Finance And Entrepreneurship from The University Of Chicago Booth School Of Business.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial